Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Prostvac
Biotech
Bavarian Nordic tanks after BMS-partnered vaccine flunks phase 3
The data monitoring committee ended the trial after ruling it would be futile to keep treating patients with the BMS-partnered Prostvac.
Nick Paul Taylor
Sep 15, 2017 8:45am
Bavarian Nordic delays phase 3 cancer vaccine data again
Jun 16, 2017 7:26am
Buffeted by headwinds, Bavarian Nordic cancels IPO
Apr 14, 2016 9:18am
